EA
NERV icon

Emerald Acquisition’s Minerva Neurosciences NERV Stock Holding History

Emerald Acquisition’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.02M Buy
9,074
+1,210
+15% +$117K ﹤0.01% 2125
2016
Q2 		$642K Buy
+7,864
New +$500K ﹤0.01% 2376

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Emerald Acquisition's NERV Position: Q3 2016 in Review

Emerald Acquisition increased its Minerva Neurosciences (NERV) stake by 15% in Q3 2016, buying an estimated $117K and bringing the position to 9,074 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2125.

Emerald Acquisition first reported a position in NERV in Q2 2016 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold NERV as of Q3 2016.

  • Emerald Acquisition held 9,074 shares of Minerva Neurosciences worth $1.02M as of Q3 2016.
  • Emerald Acquisition bought 1,210 Minerva Neurosciences shares in Q3 2016, an estimated $117K.
  • Minerva Neurosciences made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2125 holding.
  • Emerald Acquisition first reported a position in Minerva Neurosciences in Q2 2016 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.